Jun 13, 2023 / 08:20PM GMT
Andrea R. Tan - Goldman Sachs Group, Inc., Research Division - Research Analyst
Perfect. Well, thank you, everyone, for joining us this afternoon to speak with AbCellera, CEO, Carl Hansen. Thank you so much for joining us.
Carl L.G. Hansen - AbCellera Biologics Inc. - CEO, President & Chairperson
Thanks, Andrea. Great to be here.
Questions and Answers:
Andrea R. Tan - Goldman Sachs Group, Inc., Research Division - Research AnalystSo maybe to start, AbCellera, a company that's positioned at the intersection of biotech and tech, which is hot right now. But maybe for some of -- some of the people in the crowd who may be less familiar with your company, maybe describe your business thesis here and how that really helps fit you into the drug discovery and development process.
Carl L.G. Hansen - AbCellera Biologics Inc. - CEO, President & Chairperson
Great. Sure, happy to. So AbCellera was founded a little over 10 years ago. And the business thesis was essentially